Timothy R Wright
Officer, Director at Mimedx Group, Inc. (MDXG)
Timothy R Wright has filed 6 insider reports with the SEC since February 2021, as director at Protagenic Therapeutics, Inc.\new (PTIX) and officer and director at Mimedx Group, Inc. (MDXG). Timothy R Wright made no open-market purchases or sales in the last 12 months. The latest filing, on April 2, 2024, reports grant or award at Protagenic Therapeutics, Inc.\new (PTIX).
- Filings
- 6
- Companies
- 2
- Bought on market
- None
- Sold on market
- $642K
Companies where Timothy R Wright is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $0.74 | Apr 2, 2024 | |||||
| Officer, Director | 1,711,324 | $642K | $3.18 | Jun 13, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 25, 2024PTIXSEC Form 4 filed by Wright Timothy RForm 4Grant or award
- Jun 9, 2022-$420KMDXGSEC Form 4: Wright Timothy R sold $420,000 worth of shares (112,000 units at $3.75), decreasing direct ownership by 6% to 1,711,324 units to cover withholding taxForm 4Open-market sale
- Apr 8, 2022MDXGSEC Form 4: Wright Timothy R was granted 602,679 shares, increasing direct ownership by 49% to 1,823,324 unitsForm 4Grant or award
- Mar 8, 2022-$222KMDXGSEC Form 4: Wright Timothy R sold $221,624 worth of shares (45,611 units at $4.86), decreasing direct ownership by 4% to 1,220,645 units to satisfy withholding obligationForm 4Open-market sale
- Mar 4, 2021MDXGSEC Form 4: R Timothy Wright was granted 335,153 units of Common Stock, increasing direct ownership by 31% to 1,429,213 unitsForm 4Grant or award
- Feb 18, 2021MDXGSEC Form 4: R Timothy Wright disposed of $688,662 worth of Common Stock (70,200 units at $9.81), decreasing ownership by 6% to 1,094,060 unitsForm 4Shares withheld for taxes or exercise price
Also sits on boards with
Officers and directors who share two or more companies with Timothy R Wright.
Compare Timothy R Wright with
- Timothy R Wright vs Robert Benjamin Stein2 shared
- Timothy R Wright vs Garo H Armen1 shared
- Timothy R Wright vs Rice Doug1 shared
- Timothy R Wright vs Kimberly Maersk-Moller1 shared
- Timothy R Wright vs James L Bierman1 shared
- Timothy R Wright vs Dorothy E Puhy1 shared
Other insiders at the same companies
- Garo H ArmenPTIX
- Rice DougMDXG
- Kimberly Maersk-MollerMDXG
- James L BiermanMDXG
- Dorothy E PuhyMDXG
- Todd NewtonMDXG
- William A HawkinsMDXG
- Tiffany OlsonMDXG
- William Frank Hulse IVMDXG
- Joseph H CapperMDXG
- Ricci S WhitlowMDXG
- Barrett EvansPTIX
- M Kathleen BehrensMDXG
- Cato T LaurencinMDXG
Questions about Timothy R Wright
- What is Timothy R Wright's role at Mimedx Group, Inc.?
- Timothy R Wright reports to the SEC as officer and director at Mimedx Group, Inc. (MDXG), according to the latest filing on June 13, 2022. Timothy R Wright has also filed as director at Protagenic Therapeutics, Inc.\new (PTIX).
- How many shares does Timothy R Wright own?
- After the latest filing that states it, Timothy R Wright directly owned 1,711,324 shares of Mimedx Group, Inc. (MDXG). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Timothy R Wright bought or sold stock recently?
- The most recent open-market sale was on June 9, 2022: sold 112,000 shares of Mimedx Group, Inc. (MDXG) for $420K at an average of $3.75.
- How do I get alerts when Timothy R Wright files?
- Follow Timothy R Wright on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Timothy R Wright (SEC CIK 0001288245). Totals count each trade once, skipping amendments whose original is on file, from Feb 22, 2021 on. View on SEC EDGAR